The most upregulated gene in SHP2R138Q-expressing cells, considering both SHP2-driven effects and EGF-induced effects, was COBLL1 (Figure 4F and Supplementary Figure 4F), which is involved in the oncogenesis of prostate cancer and chronic lymphocytic leukemia60,61. The gene discussed is EGF; the disease is prostate cancer.